IL285984A - A method for producing a split influenza component - Google Patents

A method for producing a split influenza component

Info

Publication number
IL285984A
IL285984A IL285984A IL28598421A IL285984A IL 285984 A IL285984 A IL 285984A IL 285984 A IL285984 A IL 285984A IL 28598421 A IL28598421 A IL 28598421A IL 285984 A IL285984 A IL 285984A
Authority
IL
Israel
Prior art keywords
split vaccine
producing influenza
influenza
producing
vaccine
Prior art date
Application number
IL285984A
Other languages
English (en)
Hebrew (he)
Original Assignee
Japan As Represented By Director General Of Nat Institute Of Infectious Diseases
Sumitomo Dainippon Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan As Represented By Director General Of Nat Institute Of Infectious Diseases, Sumitomo Dainippon Pharma Co Ltd filed Critical Japan As Represented By Director General Of Nat Institute Of Infectious Diseases
Publication of IL285984A publication Critical patent/IL285984A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
IL285984A 2019-03-04 2021-08-31 A method for producing a split influenza component IL285984A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019038662 2019-03-04
PCT/JP2020/008974 WO2020179797A1 (ja) 2019-03-04 2020-03-03 インフルエンザｈａスプリットワクチンの製造方法

Publications (1)

Publication Number Publication Date
IL285984A true IL285984A (en) 2021-10-31

Family

ID=72337458

Family Applications (1)

Application Number Title Priority Date Filing Date
IL285984A IL285984A (en) 2019-03-04 2021-08-31 A method for producing a split influenza component

Country Status (14)

Country Link
US (1) US20220152191A1 (en, 2012)
EP (1) EP3936147A4 (en, 2012)
JP (1) JP7545955B2 (en, 2012)
KR (1) KR20210135261A (en, 2012)
CN (1) CN114096273A (en, 2012)
AU (1) AU2020233456A1 (en, 2012)
BR (1) BR112021017310A8 (en, 2012)
CA (1) CA3132578A1 (en, 2012)
EA (1) EA202192398A1 (en, 2012)
IL (1) IL285984A (en, 2012)
MX (1) MX2021010685A (en, 2012)
PH (1) PH12021552094A1 (en, 2012)
SG (1) SG11202109566XA (en, 2012)
WO (1) WO2020179797A1 (en, 2012)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH12021550175A1 (en) 2018-07-23 2022-07-11 Japan As Represented By Director General Of Nat Institute Of Infectious Diseases Composition containing influenza vaccine
CN114929270A (zh) * 2019-11-07 2022-08-19 塞其里斯英国有限公司 用于生产具有减小的颗粒大小的病毒疫苗的组合物和方法
WO2024225404A1 (ja) * 2023-04-26 2024-10-31 国立感染症研究所長が代表する日本国 抗インフルエンザ抗体

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2374894B1 (en) * 1993-09-13 2014-09-17 Protein Sciences Corporation A method for producing influenza hemagglutinin multivalent vaccines
US20230201329A1 (en) * 2006-07-17 2023-06-29 Glaxosmithkline Biologicals Sa Influenza vaccine
US20090181078A1 (en) * 2006-09-26 2009-07-16 Infectious Disease Research Institute Vaccine composition containing synthetic adjuvant
PE20090146A1 (es) * 2007-04-20 2009-03-23 Glaxosmithkline Biolog Sa Composicion inmunogenica contra el virus influenza
CA2744354C (en) * 2008-11-25 2018-10-02 Avir Green Hills Biotechnology Research Development Trade Ag Method for production of ph stable enveloped viruses
CN102406931B (zh) * 2011-11-25 2014-02-05 成都康华生物制品有限公司 大流行流感病毒裂解疫苗
CN104302317B (zh) * 2012-05-16 2016-07-06 Kj生物科学有限公司 新型和改进的流感疫苗
KR20140118682A (ko) 2013-03-29 2014-10-08 (주)셀트리온 2 이상의 인플루엔자 ａ 바이러스 중화 결합 분자를 포함하는 조성물
WO2016178811A1 (en) * 2015-05-04 2016-11-10 Epivax, Inc. Modified h7 hemagluttinin glycoprotein of the influenza a/shanghai/2/2013 h7 sequence
ES2805724T3 (es) * 2015-09-29 2021-02-15 Sumitomo Dainippon Pharma Co Ltd Compuestos de adenina conjugados y su uso como adyuvantes de vacunas
CN110650729B (zh) * 2017-03-29 2024-08-20 住友制药株式会社 疫苗佐剂制剂
JP7403733B2 (ja) * 2017-09-04 2023-12-25 国立感染症研究所長 インフルエンザｈａスプリットワクチンの製造方法
PH12021550175A1 (en) * 2018-07-23 2022-07-11 Japan As Represented By Director General Of Nat Institute Of Infectious Diseases Composition containing influenza vaccine
CA3121613A1 (en) * 2018-12-26 2020-07-02 Sumitomo Dainippon Pharma Co., Ltd. Preparation including vaccine adjuvant
BR112021017074A2 (pt) * 2019-02-28 2021-11-09 Novavax Inc Métodos para prevenir doença ou distúrbio causado(a) por infecção por rsv

Also Published As

Publication number Publication date
BR112021017310A2 (en, 2012) 2021-11-16
PH12021552094A1 (en) 2022-05-30
AU2020233456A1 (en) 2021-10-07
EP3936147A4 (en) 2022-09-28
WO2020179797A1 (ja) 2020-09-10
MX2021010685A (es) 2021-12-10
BR112021017310A8 (pt) 2022-12-06
US20220152191A1 (en) 2022-05-19
EA202192398A1 (ru) 2021-11-23
JP7545955B2 (ja) 2024-09-05
EP3936147A1 (en) 2022-01-12
JPWO2020179797A1 (en, 2012) 2020-09-10
CN114096273A (zh) 2022-02-25
SG11202109566XA (en) 2021-10-28
CA3132578A1 (en) 2020-09-10
KR20210135261A (ko) 2021-11-12

Similar Documents

Publication Publication Date Title
IL281220A (en) Process for preparing vaccine compositions
EP3256571A4 (en) Methods for producing virus for vaccine production
IL285984A (en) A method for producing a split influenza component
SG10201912648WA (en) Method for producing cyclododecanone
IL309408A (en) Multivalent flu vaccines
SG11201911164WA (en) Method for preparing intermediate of 4-methoxypyrrole derivative
EP3708567A4 (en) PROCESS FOR THE PREPARATION OF A BENZOFURANE DERIVATIVE
SG11202001937TA (en) Method for producing influenza ha split vaccine
EP3588654A4 (en) PROCESS FOR PRODUCING A MONOCELL
IL283331A (en) Method for the preparation of n-phenylpyrazole-1-carboxamides
EP3630722A4 (en) 4-METHOXYPYRROLE DERIVATIVE INTERMEDIATE PREPARATION PROCESS
EP3594217A4 (en) PROCESS FOR THE PRODUCTION OF DIALKYLAMINOSILANE
EP3402514A4 (en) METHOD AND COMPOSITIONS FOR INFLUENZA VACCINATION
EP3733858A4 (en) METHOD FOR PRODUCING UROLITHIN
GB202004825D0 (en) Influenza vaccines
EP3633078A4 (en) METHOD FOR MANUFACTURING A TITANIUM-COATED ELEMENT
SG11202108435WA (en) Method for virus production
PL3733651T3 (pl) Sposób wytwarzania kalkobutrolu
EP3543236A4 (en) PROCESS FOR THE PREPARATION OF AN AVIBACTAM INTERMEDIATE
EP3351534A4 (en) PROCESS FOR PREPARING A NOVEL 4-BENZAZONINE DERIVATIVE
GB201820751D0 (en) Methods for preparing intermediates
EP3689852A4 (en) DIHYDROXYINDOLS PRODUCTION PROCESS
IL311964A (en) Multivalent influenza vaccines
IL279070A (en) A method for the production of diarylpyridine derivatives
EP3763708A4 (en) METHOD OF MANUFACTURING CYCLIC ETHER